Skip to content
GLP-1 Scorecard
Menu
Graded #222

NowPatient

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Visit NowPatientWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$1,349/mo (brand Wegovy)
Tirzepatide
$1,069/mo (brand Mounjaro, promotional rate)
Coverage
Coverage not published
Brand-name
Yes

Weigh NowPatient against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value35/100
Dose & formulation93/100
Clinical oversight86/100
Labs & monitoring54/100
Fulfillment70/100
Contract terms55/100

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Bottom line — Grade C

Best for: Shoppers who want brand-name GLP-1 access without a compounded route.

Ranked #222 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest NowPatient — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect NowPatient's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.

← Back to the scorecard